This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Erectile dysfunction, exclusion
ERECTILE_EXCLUSION
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
131 |
4. Check minimum number of eventsNone |
131 |
5. Include endpointsNone |
131 |
6. Filter based on genotype QC (FinnGen only) |
131 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- I27
- Name in latin
- Hypertensio pulmonalis primaria
Similar endpoints
↥List of similar endpoints to
Erectile dysfunction, exclusion
based on the number of shared cases.
Similar with more cases:
- Secondary right heart disease
- Other pulmonary heart/vessel disease
- Pulmonary heart disease, diseases of pulmonary circulation
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 131 | - | 131 |
| Unadjusted period prevalence (%) | 0.06 | - | 0.06 |
| Median age at first event (years) | 66.15 | - | 66.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 123
- Matched controls
- 1230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I27.0
ICD-10 Finland
Primary pulmonary hypertension
+∞
110.7
89
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
72.0
38.8
43
9
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
104.3
35.1
37
5
4168X
ICD-9 Finland
Chronic pulmonary heart disease, Other chronic pulmonary heart diseases
+∞
32.8
30
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
148.5
32.5
33
*
G04BE03
ATC
sildenafil; oral
48.0
29.4
35
10
C03CA01
ATC
furosemide; systemic
8.8
26.9
91
300
C03DA01
ATC
spironolactone; oral
11.9
26.1
53
73
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
132.5
21.3
22
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
12.6
21.3
40
45
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
7.6
20.8
58
129
R06.0
ICD-10 Finland
Dyspnoea
5.6
15.1
53
147
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
11.6
14.4
27
29
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
15.4
14.1
23
18
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
4.9
14.0
57
184
C02KX04
ATC
macitentan; oral
+∞
13.8
13
*
B01AA03
ATC
warfarin; systemic
4.4
12.8
59
211
C02KX01
ATC
bosentan; oral
+∞
12.7
12
*
I50.9
ICD-10 Finland
Heart failure, unspecified
4.7
11.8
46
137
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
9.8
11.4
23
28
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
10.8
41
118
J96.1
ICD-10 Finland
Chronic respiratory failure
13.8
10.7
18
15
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.1
10.7
49
169
WX740
NOMESCO Finland
Nitrogen oxide therapy
+∞
10.6
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
9.8
71
349
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
16.8
9.8
15
10
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
8.9
9.6
20
26
4289X
ICD-9 Finland
Heart failure, unspecified
23.9
9.6
13
6
C01AA05
ATC
digoxin; systemic
4.3
9.1
37
112
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.3
9.0
28
64
H02AB06
ATC
prednisolone; systemic
3.2
8.9
75
400
XF620
NOMESCO Finland
Examination of circulation with color method
+∞
8.4
8
*
I50.0
ICD-10 Finland
Congestive heart failure
5.2
8.3
26
60
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
14.3
8.1
13
10
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
14.3
8.1
13
10
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
7.9
43
165
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.6
7.6
22
46
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.1
7.6
18
29
AP2
HP
Catheterization of the right side of the heart
32.0
7.2
9
*
A12BA01
ATC
potassium chloride; oral
8.4
7.1
15
20
A46
ICD-10 Finland
Erysipelas
3.5
6.8
33
115
WX872
NOMESCO Finland
Intensive care
6.9
6.7
16
26
R03AC02
ATC
salbutamol; inhalant
2.7
6.4
68
390
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.4
6.4
16
28
ZX108
NOMESCO Finland
Inhalation
19.2
6.4
9
5
XF400
NOMESCO Finland
ECG with 12 standard connections
3.1
6.3
38
154
XF622
NOMESCO Finland
Measurement of minute volume of heart
28.2
6.3
8
*
R4110
NOMESCO Finland
Physiotherapy
3.0
6.3
41
176
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
132
5.33
18.10
5.0
2.4
%
17.4
23.7
2.35
43
119
(3004789) Transferrin [Mass/volume] in Serum or Plasma
49
136
5.16
17.40
5.0
2.4
g/l
2.5
2.3
1.91
49
126
(4306422)
19
7
31.37
14.75
1.5
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
112
4.53
12.90
15.1
13.5
mmol/l
1.3
0.5
0.32
26
93
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
9
21.44
11.95
1.5
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
14
17
9.10
10.82
7.1
2.3
kpa
6.3
8.1
1.79
14
17
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
11
12
9.92
9.11
11.2
11.6
mg/l
11.5
9.7
0.56
11
12
(3012544) pH of Venous blood
31
97
3.88
8.91
9.3
6.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
29
88
3.95
8.69
2.8
2.9
g/l
0.2
0.2
1.13
29
79
(3032080) INR in Blood by Coagulation assay
71
378
2.92
8.37
37.2
9.6
inr
1.7
1.3
1.77
20
108
(3002032) Base excess in Venous blood by calculation
30
96
3.76
8.32
9.0
6.0
mmol/l
2.1
0.6
0.90
25
65
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
73
4.00
7.86
22.0
9.6
mmol/l
25.3
24.4
0.38
25
73
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
15
7.91
7.67
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
70
3.97
7.54
7.3
10.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
29
98
3.52
7.37
9.3
6.0
kpa
6.0
5.6
0.85
29
92
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
111
3.35
7.20
3.0
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
59
303
2.72
7.19
9.8
3.2
u/l
28.3
34.9
1.68
59
290
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
31
5.34
7.12
2.5
2.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
28
95
3.48
7.06
1.5
1.3
titre
363.6
386.0
0.06
11
20
(3042936) Bacteria identified in Isolate by Culture
33
132
3.01
6.32
3.8
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
114
3.12
6.27
3.2
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
19
6.23
6.22
2.8
1.4
—
—
—
0
0
(4268621)
10
8
13.40
6.19
3.1
3.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
20
5.91
5.91
6.9
8.7
%
58.6
66.8
0.62
11
20
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
20
5.91
5.91
2.1
2.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
38
176
2.63
5.48
19.4
1.6
mg/l
1.7
2.3
0.39
30
143
(42870588) Differential panel, method unspecified - Blood
56
312
2.39
5.44
11.7
6.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
72
448
2.35
5.42
22.1
6.9
umol/l
15.7
12.7
1.33
72
435
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
91
3.00
4.99
1.9
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
61
365
2.26
4.91
6.7
4.2
ng/l
332.1
59.4
0.42
53
266
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
8
10.55
4.58
1.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
24
96
2.84
4.53
1.2
1.2
iu/ml
36.6
33.9
—
5
29
(3013115) Eosinophils [#/volume] in Blood
69
446
2.16
4.47
11.2
7.2
e9/l
0.2
0.2
0.12
62
397
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
12
7.96
4.43
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
62
3.21
4.37
7.4
3.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
51
295
2.19
4.36
8.7
4.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
152
2.46
4.30
3.2
2.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
67
436
2.10
4.19
10.9
6.4
e9/l
0.7
0.6
0.72
59
382
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
94
2.75
4.16
1.9
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
67
437
2.09
4.15
11.0
6.4
e9/l
0.0
0.0
0.46
59
385
(3019198) Lymphocytes [#/volume] in Blood
68
447
2.08
4.12
11.4
6.6
e9/l
1.7
1.9
0.86
61
399
(3034770) Mitochondria Ab [Titer] in Serum
10
24
4.43
3.96
1.1
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
39
3.59
3.87
1.3
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
79
2.81
3.85
8.1
3.3
kpa
5.0
5.0
0.08
20
74
(3000991) Gas panel - Venous blood
23
99
2.61
3.76
22.4
9.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
21
87
2.68
3.70
8.0
4.7
kpa
4.9
4.6
0.29
21
80
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
75
2.79
3.66
2.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
128
2.40
3.62
2.0
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
52
3.13
3.60
30.5
21.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
17
5.60
3.58
7.7
2.3
kpa
5.0
4.8
—
9
17
(3026782) Osmolality of Urine
36
196
2.15
3.48
3.6
2.6
mosm/kgh2o
532.6
597.9
1.14
30
166
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
61
408
1.93
3.32
21.2
9.4
mmol/l
1.2
1.2
2.05
53
355
(40758558) Short blood count panel - Blood
36
200
2.10
3.30
8.4
6.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
28
3.78
3.26
2.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
15
5.60
3.24
5.4
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
15
5.60
3.24
1.1
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
57
376
1.91
3.21
18.9
8.2
mmol/l
1.2
1.2
3.34
52
343
(3004588) Protein electrophoresis panel - Serum or Plasma
16
62
2.80
3.18
1.3
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
20
4.75
3.17
3.8
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
57
2.84
3.09
2.7
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
8
7.79
3.09
2.0
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
8
7.79
3.09
1.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
5
10.32
3.00
1.4
1.4
%
96.6
75.8
—
5
5
(3013650) Neutrophils [#/volume] in Blood by Automated count
70
505
1.83
2.90
14.6
10.3
e9/l
4.7
4.3
0.55
63
440
(3023420) DNA double strand Ab [Units/volume] in Serum
5
6
8.60
2.77
1.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
6
8.60
2.77
2.0
1.7
u/l
208.8
133.7
—
5
6
(3045788) Cell count panel - Pleural fluid
5
6
8.60
2.77
3.0
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
18
80
2.45
2.75
7.8
4.1
%
0.2
0.8
—
6
32
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
14
55
2.73
2.72
9.4
3.9
mmol/l
24.8
24.9
0.06
14
55
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
11
5.66
2.57
4.2
3.9
e9/l
4.6
4.5
—
6
11
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
58
2.58
2.46
1.7
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
12
5.18
2.43
4.2
3.8
%
55.5
53.7
—
6
12
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
12
5.18
2.43
3.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
17
4.29
2.39
2.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
20
100
2.18
2.36
3.2
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
18
4.05
2.28
1.6
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
16
74
2.32
2.25
8.6
4.3
%
0.0
0.1
—
5
29
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
19
3.83
2.18
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
25
3.34
2.13
3.5
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
25
3.34
2.13
1.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
36
230
1.78
2.12
6.3
3.9
ph
7.4
7.4
—
8
38
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
38
248
1.75
2.08
4.0
2.3
u/l
147.8
300.4
1.24
38
236
(3023419) Bacteria identified in Sputum by Culture
6
15
4.14
2.06
4.3
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
54
390
1.65
2.04
19.4
11.0
e9/l
0.0
0.0
0.54
44
322
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
496
0.58
2.03
3.1
4.6
%
19.0
21.4
0.55
14
238
(36304419) Bacteria [Presence] in Urine
37
242
1.74
2.01
5.0
2.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
21
3.46
1.99
2.6
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
11
4.68
1.96
1.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
23
3.15
1.82
7.4
8.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
38
257
1.67
1.82
5.0
2.9
e6/l
0.2
0.4
0.48
31
194
(3017446) Testosterone [Moles/volume] in Serum or Plasma
6
146
0.38
1.78
2.2
2.1
nmol/l
9.4
14.2
—
6
134
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
18
3.44
1.77
1.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
18
3.44
1.77
2.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
18
3.44
1.77
1.0
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
13
3.95
1.73
2.2
2.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
5
13
3.95
1.73
3.8
1.5
mmol/l
1.9
1.5
—
5
13
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
25
2.90
1.67
3.9
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
28
179
1.72
1.63
9.4
4.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
14
3.67
1.63
3.8
1.2
—
—
—
0
0
(44806118)
5
14
3.67
1.63
3.4
1.3
—
—
—
0
0
(44790048)
5
14
3.67
1.63
3.4
1.3
—
—
—
0
0
(44790049)
5
14
3.67
1.63
3.4
1.3
—
—
—
0
0
(44790047)
5
14
3.67
1.63
3.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.42
1.54
2.2
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
45
330
1.55
1.53
4.5
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
40
287
1.57
1.49
4.9
3.1
e6/l
26.4
278.1
0.60
33
227
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
22
2.81
1.45
1.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
17
3.01
1.37
4.4
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
17
3.01
1.37
2.4
3.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
40
0.00
1.35
0.0
1.6
—
244.6
—
0
35
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
16
92
1.84
1.32
2.3
2.4
ug/l
11.8
11.1
0.04
16
83
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
18
2.85
1.29
1.2
1.2
u/ml
201.8
226.2
—
5
6
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
18
2.85
1.29
1.2
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
157
1.65
1.29
3.3
2.8
e6/l
0.4
0.4
0.03
12
90
(3045414) Leukocytes [Presence] in Urine
6
25
2.47
1.26
1.8
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
49
610
0.69
1.26
3.9
5.1
ug/l
2.1
2.9
0.45
43
543
(3026008) Bacteria identified in Urine by Culture
29
202
1.56
1.21
2.7
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
41
312
1.46
1.14
5.7
3.5
e6/l
56.1
93.4
0.35
33
240
(3019832) Treponema pallidum Ab [Presence] in Serum
7
31
2.33
1.12
2.1
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
31
2.33
1.12
5.4
3.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
370
0.66
1.11
2.4
3.2
ug/l
0.6
0.8
1.03
17
243
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
21
2.43
1.10
1.0
1.2
—
—
—
0
0
(3013512) EKG study
33
244
1.47
1.05
6.1
4.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21
297
0.65
0.99
2.0
3.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
37
283
1.43
0.99
3.5
2.7
u/l
50.7
55.6
0.45
37
267
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
93
1.69
0.99
4.1
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
160
1.53
0.97
3.2
2.7
e6/l
0.3
0.6
0.58
11
92
(3007853) Bacteria identified in Skin by Aerobe culture
18
118
1.61
0.97
5.8
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
27
2.28
0.95
1.2
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
68
580
1.36
0.94
9.1
4.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
69
787
0.74
0.92
4.5
4.7
mmol/l
6.2
6.2
0.10
62
712
(3000330) Specific gravity of Urine by Test strip
8
47
1.75
0.82
2.6
4.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
13
83
1.63
0.78
1.2
1.2
u/ml
64.5
14.1
—
6
28
(40761511) CBC panel - Blood by Automated count
80
883
0.76
0.77
48.2
14.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
60
515
1.30
0.75
6.0
3.9
—
342.9
—
0
14
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
24
2.12
0.75
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
7
38
1.89
0.75
12.4
4.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
38
306
1.34
0.74
2.4
2.1
pmol/l
73.2
87.2
1.85
26
182
(3016879) Cocaine [Presence] in Urine
5
25
2.04
0.73
3.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
57
1.62
0.73
4.0
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
40
1.79
0.72
1.6
2.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
63
548
1.29
0.71
6.3
3.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
28
1.82
0.67
3.4
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
28
1.82
0.67
3.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
28
1.82
0.67
3.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
28
1.82
0.67
3.4
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
20
0.00
0.61
0.0
1.2
—
3.7
—
0
20
(40768797) Stomach Pathology biopsy report
15
106
1.47
0.61
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
64
1.61
0.60
8.1
3.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.59
0.0
1.2
—
589.3
—
0
23
(3007164) IgA [Mass/volume] in Serum or Plasma
22
170
1.35
0.56
1.5
1.5
g/l
2.4
2.8
0.40
16
100
(3019225) pH of Specimen
11
74
1.53
0.55
6.3
4.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
24
194
1.29
0.46
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
22
270
0.78
0.45
1.8
2.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
55
1.48
0.44
2.9
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
32
1.58
0.42
2.4
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
32
1.58
0.42
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
5.5
—
0
9
(3011397) Hemoglobin [Presence] in Urine by Test strip
23
188
1.27
0.41
3.1
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
45
397
1.20
0.41
4.8
3.4
estimate
0.0
0.0
0.00
14
76
(3044290) Cell count panel - Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
115
0.68
0.39
1.5
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
26
220
1.23
0.35
5.3
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
44
394
1.18
0.33
6.5
4.5
estimate
0.0
0.0
0.00
15
74
(3022145) Colonoscopy Study observation
12
92
1.34
0.33
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
45
406
1.17
0.31
4.7
3.4
estimate
0.0
0.0
0.00
15
70
(3012516) Albumin [Mass/volume] in Urine
29
253
1.19
0.29
3.9
3.5
mg/l
44.0
294.2
0.59
22
185
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
40
360
1.16
0.28
7.1
4.6
—
—
—
0
0
(4035726)
8
67
1.21
0.27
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
25
219
1.17
0.24
5.1
3.7
estimate
0.0
0.0
0.49
14
68
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
29
261
1.14
0.20
4.6
2.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
4.7
—
0
14
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
271
1.14
0.20
4.8
4.3
mg/mmol
5.6
11.6
1.05
24
194
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
34
313
1.12
0.17
4.9
3.7
—
—
—
0
0
(4010399)
8
68
1.19
0.17
2.0
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
199
1.13
0.14
4.5
2.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
16
145
1.12
0.10
3.4
3.1
mmol/l
2.4
2.5
0.06
11
126
(40761535) Cells panel - Urine sediment
7
63
1.12
0.08
1.9
3.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
84
1.08
0.07
11.2
9.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
75
766
0.95
0.07
44.4
14.7
ml/min/173m2
72.7
79.4
1.49
69
637
(3009542) Hematocrit [Volume Fraction] of Blood
74
752
0.96
0.04
58.8
17.5
%
39.3
40.4
0.42
54
559
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
48
489
0.97
0.02
3.5
3.0
—
—
—
0
0
(3000492) Spirometry study
10
101
0.99
0.00
1.7
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
245.7
—
0
7
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
7.6
—
0
5
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
10.7
—
0
7
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
18
180
1.00
0.00
4.4
3.6
kg/l
1.0
1.0
—
7
23
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
35.8
—
0
5
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
133.7
—
0
6
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
1.5
—
12.8
—
0
6
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
4.1
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
9
90
1.00
0.00
1.1
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
1.8
—
0
6
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
16.2
—
1059.8
—
0
9
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
11.1
—
615.3
—
0
9
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
13.7
—
7.2
—
0
6
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
9
0.00
0.00
0.0
2.1
—
2.1
—
0
9
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.8
—
0
7
(3026470) Cobalt [Mass/volume] in Blood
0
9
0.00
0.00
0.0
2.1
—
3.5
—
0
9
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ERECTILE_EXCLUSION – Erectile dysfunction, exclusion
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).